Ausgabe 2/2011
Inhalt (36 Artikel)
CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status
Hyun Mi Kim, Choung-Soo Kim, Je-Hwan Lee, Se Jin Jang, Jung Jin Hwang, Seonggu Ro, Young-Lan Hyun, Jene Choi
Significance of ER–Src axis in hormonal therapy resistance
Sreeram Vallabhaneni, Binoj C. Nair, Valerie Cortez, Rambabu Challa, Dimple Chakravarty, Rajeshwar Rao Tekmal, Ratna K. Vadlamudi
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
Puspa R. Pandey, Hiroshi Okuda, Misako Watabe, Sudha K. Pai, Wen Liu, Aya Kobayashi, Fei Xing, Koji Fukuda, Shigeru Hirota, Tamotsu Sugai, Go Wakabayashi, Keisuke Koeda, Masahiro Kashiwaba, Kazuyuki Suzuki, Toshimi Chiba, Masaki Endo, Tomoaki Fujioka, Susumu Tanji, Yin-Yuan Mo, Deliang Cao, Andrew C. Wilber, Kounosuke Watabe
P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis
Robin Fuchs-Young, Stephanie H. Shirley, Isabel Lambertz, Jennifer K. L. Colby, Jie Tian, Dennis Johnston, Irma B. Gimenez-Conti, Lawrence A. Donehower, Claudio J. Conti, Stephen D. Hursting
Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance
Thomas Karn, Eugen Ruckhäberle, Lars Hanker, Volkmar Müller, Marcus Schmidt, Christine Solbach, Regine Gätje, Mathias Gehrmann, Uwe Holtrich, Manfred Kaufmann, Achim Rody
Struggling with subtypes: trying to bridge the gap between molecular breast cancer subtypes and clinical management
Nadia Harbeck
A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients
M. A. Didraga, E. H. van Beers, S. A. Joosse, K. I. M. Brandwijk, R. A. Oldenburg, L. F. A. Wessels, F. B. L. Hogervorst, M. J. Ligtenberg, N. Hoogerbrugge, S. Verhoef, P. Devilee, P. M. Nederlof
Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy
Scott Thomas, Kenneth T. Thurn, Elona Biçaku, Douglas C. Marchion, Pamela N. Münster
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
Cristina Raimondi, Angela Gradilone, Giuseppe Naso, Bruno Vincenzi, Arianna Petracca, Chiara Nicolazzo, Antonella Palazzo, Rosa Saltarelli, Franco Spremberg, Enrico Cortesi, Paola Gazzaniga
Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study
D. G. Powe, M. J. Voss, H. O. Habashy, K. S. Zänker, A. R. Green, I. O. Ellis, F. Entschladen
IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
M. P. Roberti, M. M. Barrio, A. I. Bravo, Y. S. Rocca, J. M. Arriaga, M. Bianchini, J. Mordoh, E. M. Levy
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
Sibylle Loibl, Berit Maria Müller, Gunter von Minckwitz, Michael Schwabe, Marc Roller, Silvia Darb-Esfahani, Beyhan Ataseven, Andreas du Bois, Annette Fissler-Eckhoff, Bernd Gerber, Uwe Kulmer, Jens-Uwe Alles, Keyur Mehta, Carsten Denkert
A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments
Yahong Wang, Quangui Yin, Qi Yu, Jing Zhang, Ziyu Liu, Shuling Wang, Shuhua Lv, Yun Niu
Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype
Hee Jeong Kim, Wonshik Han, On Vox Yi, Hee Chul Shin, Soo-Kyung Ahn, Beom Seok Koh, Hyeong-Gon Moon, Jong Han You, Byung Ho Son, Sei Hyun Ahn, Dong-Young Noh
Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society
Sei Hyun Ahn, Hee Jeong Kim, Jong Won Lee, Gyung-Yub Gong, Dong-Yong Noh, Jung Hyun Yang, Sang Seol Jung, Ho Yong Park
Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case–control study
Xiao-Feng He, Jiao Su, Ying Zhang, Xian Huang, Yi Liu, Da-Peng Ding, Wei Wang, K. Arparkorn
Unmet supportive care needs: a cross-cultural comparison between Hong Kong Chinese and German Caucasian women with breast cancer
Wendy W. T. Lam, Angel H. Y. Au, Jennifer H. F. Wong, Claudia Lehmann, Uwe Koch, Richard Fielding, Anja Mehnert
Effect of false-positives and women’s characteristics on long-term adherence to breast cancer screening
R. Román, M. Sala, M. De La Vega, C. Natal, J. Galceran, I. González-Román, A. Baroja, R. Zubizarreta, N. Ascunce, D. Salas, X. Castells
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden
Theodoros Foukakis, Tommy Fornander, Tobias Lekberg, Henrik Hellborg, Jan Adolfsson, Jonas Bergh
Association between polymorphisms of the renin–angiotensin system genes and breast cancer risk: a meta-analysis
Bo Xi, Tao Zeng, Liu Liu, Yajun Liang, Weina Liu, Yuehua Hu, Jun Li
Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy
Lisa Gallicchio, Ryan MacDonald, Bethany Wood, Errol Rushovich, Kathy J. Helzlsouer
Long-term course of pain in breast cancer survivors: a 4-year longitudinal study
Winfried Rief, Wayne A. Bardwell, Joel E. Dimsdale, Loki Natarajan, Shirley W. Flatt, John P. Pierce
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger
Mia M. Gaudet, Michael F. Press, Robert W. Haile, Charles F. Lynch, Sally L. Glaser, Joellen Schildkraut, Marilie D. Gammon, W. Douglas Thompson, Jonine L. Bernstein
Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups
Alexandra J. van den Broek, Annegien Broeks, Hugo M. Horlings, Sander V. M. Canisius, Linde M. Braaf, Anita Langerød, Laura J. Van’t Veer, Marjanka K. Schmidt
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses
Voralak Vichapat, Hans Garmo, Lars Holmberg, Ian S. Fentiman, Andrew Tutt, Cheryl Gillett, Margreet Lüchtenborg
Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care
Jennifer S. Haas, Su-Ying Liang, Michael J. Hassett, Stephen Shiboski, Elena B. Elkin, Kathryn A. Phillips
Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: a multi-institution survey
K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi
Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity
Rita A. Mukhtar, Amy P. Moore, Onouwem Nseyo, Frederick L. Baehner, Alfred Au, Dan H. Moore, Patrick Twomey, Michael J. Campbell, Laura J. Esserman
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
Fangfang Liu, Ronggang Lang, Jing Zhao, Xinmin Zhang, Gordon A. Pringle, Yu Fan, Dong Yin, Feng Gu, Zhi Yao, Li Fu
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
Michelle D. Holmes, Wendy Y. Chen, Stuart J. Schnitt, Laura Collins, Graham A. Colditz, Susan E. Hankinson, Rulla M. Tamimi
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
Mark Mackiewicz, Konrad Huppi, Jason J. Pitt, Tiffany H. Dorsey, Stefan Ambs, Natasha J. Caplen
Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer
Larissa Nekhlyudov, Lingling Li, Dennis Ross-Degnan, Anita K. Wagner
What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
Dora Il’yasova, Sharareh Siamakpour-Reihani, Igor Akushevich, Lucy Akushevich, Neil Spector, Joellen Schildkraut
Predicting lymphatic drainage patterns and primary tumour location in patients with breast cancer
Evan I. Blumgart, Roger F. Uren, Poul M. F. Nielsen, Martyn P. Nash, Hayley M. Reynolds
Anti-cytokeratin CAM 5.2 (B.D. Biosciences) has a primary reactivity with CK 7 and CK 8 (48 and 52 kD) rather than with the smaller molecular weight keratin breakdown fractions (50, 43, and 38 kD)
Chung-Chin Yao, Wea-Lung Lin, Ming-Yung Lee, Chih-Ping Han
A Halsted mastectomy 21 years before Halsted
Gregory Tsoucalas, Antonis A. Kousoulis, Lazaros Vladimiros, George Androutsos